| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |